High-intensity Statin and Ezetimibe Therapy for Asymptomatic Patients With Positive Coronary Calcium
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 6000 participants.
Also called NCT05845424
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 6,000 participants
- Sponsor
- Registry
-
NCT05845424
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Recruiting
Technical summary
Registry record NCT05845424. Randomized; no masking; primary purpose treatment. Start 2023-07-03 (actual); primary completion 2029-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- High-intensity Statin and Ezetimibe Therapy for Asymptomatic Patients With Positive Coronary Calcium
- Acronym
- DECISION-CAL
- Condition
- Coronary Artery Calcification
- Condition
- Metabolic Syndrome
- Condition
- Dyslipidemias
- Intervention (Drug)
- Guideline directed statin therapy
- Intervention (Drug)
- High intensity statin plus ezetimibe therapy
- Lead sponsor
- Samsung Medical Center
Record details
- Record id
cardio:ct-nct05845424- Content hash
a21e901397f41f60d13f44c6bdfd1716f431710e041591e7e82016cfa90800bb